Justin J. McAnear Insider Profile
4 Followers
Justin J. McAnear, Former Chief Financial Officer at 10x Genomics, holds 37.22K shares in Alamar Biosciences, Inc. (Ticker: ALMR), holds 143.24K shares in 10x Genomics (Ticker: TXG).
Justin J. McAnear 10x Genomics (TXG)Former Chief Financial Officer
10x Genomics (TXG)
Former Chief Financial Officer
Ranked #3,252 out of 107,043 Corporate Insiders
Profitable Transactions
10 out of 13 Profitable Transactions
Average Return
+38.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Justin J. McAnear holds in companies
Most Profitable Insider Trade
The most profitable trade made by Justin J. McAnear
Justin J. McAnear's Trading History
10x Genomics
Aug 26, 2024
Former Chief Financial Officer
Informative Sell
66.68K
$3.19M
Alamar Biosciences, Inc.
Apr 20, 2026
Chief Financial Officer
Uninformative Buy
―
$993.40K
List of latest transactions for each holding click on a transaction to see Justin J. McAnear's performance on stock
You May Also Like
Justin J. McAnear insider profile FAQ
What is the percentage of profitable transactions made by Justin J. McAnear?
The percentage of profitable transactions made by Justin J. McAnear is 77%.
What is the average return per transaction made by Justin J. McAnear?
The average return per transaction made by Justin J. McAnear is 38.20%.
What stocks does Justin J. McAnear hold?
Justin J. McAnear holds: TXG, ALMR stocks.
What was Justin J. McAnear’s latest transaction?
Justin J. McAnear latest transaction was an Uninformative Buy of ―.
What was Justin J. McAnear's most profitable transaction?
Justin J. McAnear’s most profitable transaction was an Informative Sell of TXG stock on August 25, 2021. The return on the trade was 76.80%.
What is Justin J. McAnear's role in 10x Genomics?
Justin J. McAnear's role in 10x Genomics is Former Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.